ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000270750.1	ABT-263 (navitoclax)	Lymphoid neoplasm diffuse large B-cell lymphoma	0.049534166	Resistant
ENSG00000270750.1	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.049139426	Sensitive